Role of radioiodine in the treatment of local thyroid cancer

International Journal of Radiation Oncology Biology Physics

Volumn 36, Issue 1, 1996, Pages 263-265

  Tubiana, M ^a  

^a Centre Antoine Beclere   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

CANCER RADIOTHERAPY; EDITORIAL; HUMAN; PRIORITY JOURNAL; RADIOIODINATION; RADIOISOTOPE THERAPY; THYROID CANCER;

EID: 0029789271     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00309-4     Document Type: Editorial

References (36)

1. M.W. Ashcraft A.J. Van Herle The comparative value of serum thyroglobulin measurements and iodine 131 total body scans in the follow-up study of patients with treated differentiated thyroid cancer Am. J. Med. 71 1981 806 814
2. W.H. Beierwaltes Carcinoma of the thyroid. Radionuclide diagnosis, therapy and follow-up Clin. Oncol. 5 1986 23 27
3. H. Brincker H.S. Hansen A.P. Andersen Induction of leukemia by 131I treatment of thyroid carcinoma Br. J. Cancer 28 1973 232 237
4. B. Cady R. Rossi An expanded view of risk-group definition in differentiated thyroid carcinoma Surgery 104 1988 947 953
5. D. Casara D. Rubello G. Saladini A. Piotto M.R. Pelizzo M.E. Girelli B. Busnardo pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: Potential risks and recommendations Eur. J. Nucl. Med. 20 1993 192 194
6. R. Coliez M. Tubiana S. Sung Disparition des métastases pulmonaires d'un cancer thyroïdien sous l'influence de l'iode radioactif J. Radiol. Electrol. (Paris) 32 1975 396 398
7. M.E. Dottorini G. Lomuscio L. Mazzucchelli A. Vignati L. Colombo Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma J. Nucl. Med. 36 1995 21 27
8. A.J. Dulgeroff J.M. Hershman Medical therapy for differentiated thyroid carcinoma Endocr. Rev. 15 1994 500 515
9. C.J. Edmonds T. Smith The long-term hazards of the treatment of thyroid cancer with radioiodine Br. J. Radiol. 59 1986 45 51
10. P. Hall L.E. Holm G. Lundell G. Bjelkengren L.G. Larsson S. Lindberg J. Tennvall H. Wicklund J.D. Boice Cancer risks in thyroid cancer patients Br. J. Cancer 64 1991 159 163
11. I.D. Hay E.J. Bergstralh J.R. Goellner J.E. Ebersold C.S. Grant Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989 Surgery 114 1993 1050 1058
12. S. Mariotti P. Barbesino P. Caturegli M. Marino L. Manetti F. Pacini Centoni A. Pinchera Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? J. Clin. Endocrinol. Metab. 80 1995 468 472
13. H.R. Maxon H.S. Smith Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer Endocrinol. Metab. Clin. North Am. 19 1990 685 718
14. E.L. Mazzaferri S.M. Jhiang Long term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer Am. J. Med. 97 1994 418 428
15. M. Ozata S. Suzuki T. Miyamoto R.T. Liu F. Fierro-Renoy L.J. De Groot Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer J. Clin. Endocrinol. Metab. 79 1994 98 105
16. S.B. Parayani R.J. Chobe W. Scott J. Wells D. Jonson A. Kuruvilla S. Schoeppel A. Deshmukh R. Miller L. Dajani C.T. Montgomery E. Puestow J. Purcell M. Roura D. Sutton Mallett J. Peer Management of thyroid cancer with radioactive iodine-131 Int. J. Radiat. Oncol. Biol. Phys. 36 1996 83 86
17. J.J. Ryan I.D. Hay C.S. Grant L.M. Rainwater G.M. Farrow J.R. Goellner Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid World J. Surg. 12 1988 482 487
18. A. Sakamoto N. Kasai H. Sugano Poorly differentiated carcinoma of the thyroid. A clinico-pathologic entity for a high risk group of papillary and follicular carcinomas Cancer 52 1983 1846 1853
19. N.A. Samaan P.N. Schultz R.C. Hickey H. Goepfert T.P. Haynie D.A. Johnson N.G. Ordonez The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients J. Clin. Endocrinol. Metab. 75 1992 714 720
20. 131I for thyroid cancer J. Nucl. Med. 17 1976 460 464
21. M. Schlumberger O. Arangioli J.D. Piekarski M. Tubiana C. Parmentier Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-ray J. Nucl. Med. 29 1988 1790 1794
22. M. Schlumberger C. Challeton F. De Vathaire J.P. Travagli P. Gardet J.D. Lumbroso C. Francese F. Fontaine M. Ricard C. Parmentier Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma J. Nucl. Med. 37 1996 598 605
23. M. Schlumberger F. De Vathaire C. Ceccarelli M.J. Delisle C. Francese J.E. Couette A. Pinchera C. Parmentier Exposure to radioactive iodine (131-I) for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients J. Nucl. Med. 37 1996 606 612
24. M. Schlumberger F. De Vathaire J.P. Travagli G. Vassal J. Lemerle C. Parmentier M. Tubiana Differentiated thyroied carcinoma in childhood: long term follow-up of 72 patients J. Clin. Endocrinol. Metab. 65 1987 1088 1094
25. M. Schlumberger P. Fragu J. Lumbroso D. Violot C. Parmentier A new immunoradiometric assay (IRMA) system for thyroglobulin measurement in the follow-up of thyroid cancer patients Eur. J. Nucl. Med. 18 1991 153 157
26. M. Schlumberger P. Fragu C. Parmentier M. Tubiana Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: comparison of its value in patients with or without normal residual tissue Acta Endocrinol. (Kbh) 98 1981 215 221
27. 131I and external radiation in the treatment of local and metastatic thyroid cancer S.A. Falk Thyroid disease 1990 Raven Press New York 537 552
28. 131I scans in the follow-up of thyroid cancer patients J.I. Hamburger Diagnostic methods in clinical thyroidology 1989 Springer-Verlag New York 147 157
29. M. Schlumberger M. Tubiana F. De Vathaire C. Hill P. Gardet J.P. Travagli P. Fragu J. Lumbroso B. Caillou C. Parmentier Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma J. Clin. Endocrinol. Metab. 63 1986 960 967
30. J.P. Shah T.R. Loree D. Dharker E.W. Strong C. Begg V. Vlamis Prognostic factors in differentiated carcinoma of the thyroid gland Am. J. Med. 164 1992 658 661
31. W.J. Simpson T. Panzarella J.S. Carruthers M.K. Gospodarowicz S.B. Sutcliffe Papillary and follicular thyroid cancer: impact of treatment in 1578 patients Int. J. Radiat. Oncol. Biol. Phys. 14 1988 1063 1075
32. J. Tennvall A. Biörklund T. Möller J. Ranstam M. Äkerman Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up Cancer 57 1986 1405 1414
33. M. Tubiana E. Haddad M. Schlumberger C. Hill P. Rougier D. Sarrazin External radiotherapy in thyroid cancers Cancer 55 1985 2062 2071
34. M. Tubiana J. Lacour J.P. Monnier C. Bergiron R. Gerard-Marchant J. Roujeau B. Bok C. Parmentier External radiotherapy and radioiodine in the treatment of 359 thyroid cancers Br. J. Radiol. 48 1975 894 907
35. M. Tubiana J.P. Mabille L'iode radioactif et le cancer de la thyroïde. Problèmes diagnostiques J. Radiol. Electrol. (Paris) 44 1963 179 186
36. M. Tubiana M. Schlumberger P. Rougier A. Laplanche E. Benhamou P. Gardet B. Caillou J.P. Travagli C. Parmentier Long term results and prognostic factors in patients with differentiated thyroid carcinoma Cancer 55 1985 794 804